Journals / Türk Biyokimya Dergisi / 2019 / Cilt: 44 - Sayı: 5

Association between serum vitamin D level and liver MRI T2 star in patients with β-thalassemia major

β-Talasemi Major Hastalarında Karaciğer MRI T2 skoru ile Serum Vitamin D düzeyleri arasındaki İlişki

Pages
594–598
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Vitamin D deficiency (

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractBackground: Iron overloaded Beta Thalassemia major (β-TM) patients have a high risk of liver problems.
📊
Key Findings & Data:In recent years studies revealed that vitamin D level is decreased inchronic liver diseases.
💡
Conclusion & Impact:Vitamin D deficiency (
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AbstractBackground: Iron overloaded Beta Thalassemia major (β-TM) patients have a high risk of liver problems. In recent years studies revealed that vitamin D level is decreased inchronic liver diseases. The present study was designed to find the association between the serum vitamin D levels and the liver iron deposition in patients with β-TM.Materials and methods: A total of 101 patients with a diagnosis of β-TM were included into this study. The patients were divided into four groups according to liver T2* MRIscores (group 1: normal, group 2: mild iron load, group 3: moderate iron load and group 4: severe iron load). Serum vitamin D was measured by chemiluminescence immunoassay method.Results: The vitamin D level was median 14 (4–91) ng/mL. There was a positive correlation between vitamin D levels and liver T2* MRI scores (r = 0.31, p < 0.05). There is a significant difference between groups 1 and 4 for vitamin D level (p < 0.05). Vitamin D deficiency (

Özet

ÖzAmaç: Beta talasemi major (β-TM) tüm dünyada sık görülen genetik bir hastalıktır. Aşırı demir yüklenmesi olan β-TM hastalarında karaciğer ve kalp problemleri sık görülmekte ve yaşam beklentisi azalmaktadır. Son yıllarda yapılan çalışmalarda kronik karaciğer hastalıkları ile düşük vitamin D düzeyleri arasındaki ilişki vurgulanmaktadır. Bu çalışmamızda β-TM hastalarında karaciğer demir birikimi ile vitamin D düzeyleri arasındaki ilişkiyi araştırdık.Gereç ve Yöntem: Çalışmaya 101 β-TM tanılı hasta dahil edildi. Hastalar karaciğer T2* MRI skoruna göre dört gruba ayrıldı. (Grup 1: normal, grup 2: hafif düzeyde demir birikimi, grup 3: orta düzeyde demir birikimi, grup 4: hafif düzeyde demir birikimi). Serum vitamin D düzeyleri kemiluminesans immunoassay yöntemi ile ölçüldü.Bulgular: Ortalama T2* skoru 5.86 ± 7.68 ms idi. Vitamin D düzeyleri ortanca 14 (4–91) ng/mL olarak ölçüldü. Vitamin D düzeyleri ile karaciğer T2* MRI skoru arasında pozitif korelasyon olduğu tespit edildi (r = 0,31, p < 0,05). Grup 1 ve 4 arasında vitamin D düzeylerinin anlamlı düzeyde farklı olduğu bulundu (p < 0,05). Vitamin D eksikliği (

🔖

Cite This Article

KOÇTEKİN, B., UĞUR, S., BOZKURT, S., KURTOĞLU, E., KURTOĞLU, A. U. (2022). Association between serum vitamin D level and liver MRI T2 star in patients with β-thalassemia major. Türk Biyokimya Dergisi, Cilt: 44 - Sayı: 5, 594–598. https://ajindex.com/articles/620875

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Chen EQ, Shi Y, Tang H. New insight of vitamin D in chronic liver diseases. Hepatobiliary Pancreat Dis Int 2014;13:580–5
  2. Stokes CS, Lammert F. Vitamin D supplementation: less controversy, more guidance needed. F1000Res 2016; 5:pii: F1000
  3. Trummer C, Pandis M, Verheyen N, Grübler MR, Gaksch M, Obermayer-Pietsch B, et al. Beneficial effects of UV-radiation: vitamin D and beyond. Int J Environ Res Public Health 2016;13:1028
  4. Tagliabue E, Raimondi S, Gandini S. Meta-analysis of vitamin D-binding protein and cancer risk. Cancer Epidemiol Biomarkers Prev 2015;24:1758–65
  5. Rana S, Morya RK, Malik A, Bhadada SK, Sachdeva N, Sharma G. A relationship between vitamin D, parathyroid hormone, calcium levels and lactose intolerance in type 2 diabetic patients and healthy subjects. Clin Chim Acta 2016;462:174–7
  6. Ginzburg Y, Rivella S. β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 2011;118:4321–30
  7. Bahnasawy SM, El Wakeel LM, El Beblawy N, El-Hamamsy M. Clinical pharmacist-provided services in iron overloaded β-thalassemia major children; a new insight to patient care. Basic Clin Pharmacol Toxicol 2017;120:354–9
  8. Eghbali A, Taherahmadi H, Shahbazi M, Bagheri B, Ebrahimi L. Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major β-thalassemia. Iran J Ped Hematol Oncol 2014;4:17–21
  9. Ren Y, Liu M, Zhao J, Ren F, Chen Y, Li JF, et al. Serum vitamin D₃ does not correlate with liver fibrosis in chronic hepatitis C. World J Gastroenterol 2015;21:11152–9
  10. Hoan NX, Khuyen N, Binh MT, Giang DP, Van Tong H, Hoan PQ, et al. Association of vitamin D deficiency with hepatitis B virus – related liver diseases. BMC Infect Dis 2016;16:507
  11. Casale M, Citarella S, Filosa A, De Michele E, Palmieri F, Ragozzino A, et al. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. Am J Hematol 2014;89:1102–6
  12. Altincik A, Akin M. Prevalence of endocrinopathies in Turkish children with β-thalassemia major: a single-center study. J Pediatr Hematol Oncol 2016;38:389–93
  13. Ambarwati L, Rahayuningsih SE, Setiabudiawan B. Association between vitamin D levels and left ventricular function and NT-proBNP levels among thalassemia major children with iron overload. Ann Pediatr Cardiol 2016;9:126–31
  14. Giusti A, Pinto V, Forni GL, Pilotto A. Management of β-thalassemia-associated osteopo